Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $40.30 USD
Change Today -0.01 / -0.02%
Volume 2.9K
HAE On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 9:40 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

haemonetics corp/mass (HAE) Snapshot

Open
$40.40
Previous Close
$40.37
Day High
$40.48
Day Low
$40.24
52 Week High
02/27/15 - $45.43
52 Week Low
10/20/14 - $33.75
Market Cap
2.1B
Average Volume 10 Days
329.6K
EPS TTM
$1.23
Shares Outstanding
51.0M
EX-Date
--
P/E TM
32.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for HAEMONETICS CORP/MASS (HAE)

Related News

No related news articles were found.

haemonetics corp/mass (HAE) Related Businessweek News

No Related Businessweek News Found

haemonetics corp/mass (HAE) Details

Haemonetics Corporation designs, manufactures, and markets blood management solutions. The company operates through North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific, and Japan segments. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components in the lab; and manual collection, filtration, and processing products. The company also offers hospital products comprising TEG thrombelastograph hemostasis analyzer systems that measure a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver systems for cardiovascular surgeries; and OrthoPAT surgical blood salvage systems for orthopedic procedures. In addition, it provides IMPACT Online blood management portal to monitor the results of its new blood management practices; SafeTrace Tx that manages blood product inventory and transfusions, and performs patient cross-matching; BloodTrack to manage tracking and control of blood products from the hospital blood center; and SafeTrace and El Dorado Donor donation and blood unit management systems, as well as Hemasphere, Donor Doc, and e-Donor software solutions. The company markets and sells its products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.

3,383 Employees
Last Reported Date: 05/22/15
Founded in 1971

haemonetics corp/mass (HAE) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $640.2K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $478.3K
Chief Operating Officer
Total Annual Compensation: $401.9K
Executive Vice President of Global Quality an...
Total Annual Compensation: $717.3K
Executive Vice President of Global Manufactur...
Total Annual Compensation: $455.0K
Compensation as of Fiscal Year 2015.

haemonetics corp/mass (HAE) Key Developments

Haemonetics Corporation Presents at Goldman Sachs 36th Annual Global Healthcare Conference, Jun-10-2015 02:40 PM

Haemonetics Corporation Presents at Goldman Sachs 36th Annual Global Healthcare Conference, Jun-10-2015 02:40 PM. Venue: Terranea Resort, Rancho Palos Verdes, California, United States. Speakers: Christopher J. Lindop, Chief Financial Officer and Executive Vice President of Business Development.

Haemonetics Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 08:30 AM

Haemonetics Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 08:30 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Brian P. Concannon, Chief Executive Officer, President and Director.

Haemonetics Corporation Presents at Three Part Advisors East Coast IDEAS Investor Conference 2015, Jun-04-2015 02:30 PM

Haemonetics Corporation Presents at Three Part Advisors East Coast IDEAS Investor Conference 2015, Jun-04-2015 02:30 PM. Venue: Boston Park Plaza, 50 Park Plaza at Arlington St., Boston, MA 02116, United States. Speakers: Gerard J. Gould, Vice President of Investor Relations.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAE:US $40.30 USD -0.01

HAE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $68.21 USD -0.02
Fresenius SE & Co KGaA €58.69 EUR +1.41
McKesson Corp $225.02 USD +0.44
Medtronic PLC $73.40 USD -0.13
Terumo Corp ¥3,070 JPY +40.00
View Industry Companies
 

Industry Analysis

HAE

Industry Average

Valuation HAE Industry Range
Price/Earnings 100.0x
Price/Sales 2.3x
Price/Book 2.5x
Price/Cash Flow 121.9x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAEMONETICS CORP/MASS, please visit www.haemonetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.